Dr. Bohnsack is a recognized thought leader in oncology trial imaging, especially regarding the use of standardized review criteria and imaging based endpoints with a more recent focus on immune-oncology.
25+ years of clinical trial imaging experience
Led and managed the imaging components of more than 600 oncology clinical trials
Supported with his contributions the approval of 25+ oncology medications.
Co-author of the immune-related response criteria (irRC, 2009)
First author of irRECIST (2014)
Co-author of Comparison of Assessments using RECIST 1.1 and irRECIST by Manitz J, Eggleton P. et al. (JITC 2022).
